Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7611835rdf:typepubmed:Citationlld:pubmed
pubmed-article:7611835lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:7611835lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:7611835pubmed:issue5lld:pubmed
pubmed-article:7611835pubmed:dateCreated1995-8-17lld:pubmed
pubmed-article:7611835pubmed:abstractTextA new class of heteroaromatic analogs of lignans, called heterolignanolides, have been tested against several tumor cell lines. These compounds carry diverse heterocyclic rings, instead of the trimethoxyphenyl ring found in the natural lignans yatein and podorhizol. They have moderate antineoplastic activity (P-388, A-549, HT-29) compared with that of yatein. None of the tested compounds has discernible antiviral (HSV-1, VSV) or enzyme inhibitor (ADA, DHFR, GST) activity.lld:pubmed
pubmed-article:7611835pubmed:languageenglld:pubmed
pubmed-article:7611835pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7611835pubmed:citationSubsetIMlld:pubmed
pubmed-article:7611835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7611835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7611835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7611835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7611835pubmed:statusMEDLINElld:pubmed
pubmed-article:7611835pubmed:monthMaylld:pubmed
pubmed-article:7611835pubmed:issn0365-6233lld:pubmed
pubmed-article:7611835pubmed:authorpubmed-author:ToméFFlld:pubmed
pubmed-article:7611835pubmed:authorpubmed-author:LópezJ LJLlld:pubmed
pubmed-article:7611835pubmed:authorpubmed-author:MedardeMMlld:pubmed
pubmed-article:7611835pubmed:authorpubmed-author:Peláez-Lamami...lld:pubmed
pubmed-article:7611835pubmed:authorpubmed-author:GrávalosD GDGlld:pubmed
pubmed-article:7611835pubmed:authorpubmed-author:San...lld:pubmed
pubmed-article:7611835pubmed:issnTypePrintlld:pubmed
pubmed-article:7611835pubmed:volume328lld:pubmed
pubmed-article:7611835pubmed:ownerNLMlld:pubmed
pubmed-article:7611835pubmed:authorsCompleteYlld:pubmed
pubmed-article:7611835pubmed:pagination403-7lld:pubmed
pubmed-article:7611835pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:meshHeadingpubmed-meshheading:7611835-...lld:pubmed
pubmed-article:7611835pubmed:year1995lld:pubmed
pubmed-article:7611835pubmed:articleTitleHeterolignanolides: antitumor activity of furyl-, thienyl-, and pyridyl analogs of lignanolides.lld:pubmed
pubmed-article:7611835pubmed:affiliationDept Química Orgánica y Farmacéutica. Fac. Farmacia., Salamanca, Spain.lld:pubmed
pubmed-article:7611835pubmed:publicationTypeJournal Articlelld:pubmed